Edgestream Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Edgestream Partners's RLAY Position: Q3 2026 in Review
Edgestream Partners opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 210,889 shares worth $3.81M. The stake represents 0.1% of the portfolio and ranks #384 among its holdings.
259 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Edgestream Partners held 210,889 shares of Relay Therapeutics worth $3.81M as of Q3 2026.
- Relay Therapeutics was a new Edgestream Partners position in Q3 2026.
- Relay Therapeutics made up 0.1% of Edgestream Partners's portfolio in Q3 2026, its #384 holding.
- 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Edgestream Partners's 13F filing for Q3 2026, filed 10 Nov 2026.